Ngā hua rapu - David Voduc
- E whakaatu ana i te 1 - 10 hua o te 10
-
1
Tissue Microarrays in Clinical Oncology mā David Voduc, Challayne Kenney, Torsten O. Nielsen
I whakaputaina 2008Revisão -
2
-
3
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases mā Ashish Rajput, Dmitry Turbin, Maggie C.U. Cheang, David Voduc, Sam Leung, Karen A. Gelmon, C. Blake Gilks, David G. Huntsman
I whakaputaina 2007Artigo -
4
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype mā Maggie C.U. Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen Chia, Charles M. Perou, Torsten O. Nielsen
I whakaputaina 2008Artigo -
5
-
6
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer mā Maggie C.U. Cheang, Stephen Chia, David Voduc, Dongxia Gao, Samuel Leung, Jacqueline Snider, Mark Watson, Sherri R. Davies, Philip S. Bernard, Joel S. Parker, Charles M. Perou, Matthew J. Ellis, Torsten O. Nielsen
I whakaputaina 2009Artigo -
7
Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial mā Maggie C.U. Cheang, K. David Voduc, Dongsheng Tu, Shan Jiang, Samuel Leung, Stephen Chia, Lois E. Shepherd, Mark N. Levine, Kathleen I. Pritchard, Sherri R. Davies, Inge J. Stijleman, Carole Davis, Mark Ebbert, Joel S. Parker, Matthew J. Ellis, Philip S. Bernard, Charles M. Perou, Torsten O. Nielsen
I whakaputaina 2012Artigo -
8
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes mā Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang, Samuel Leung, David Voduc, Tammi L. Vickery, Sherri R. Davies, Christiane Fauron, Xiaping He, Zhiyuan Hu, John F. Quackenbush, Inge J. Stijleman, Juan Palazzo, J. S. Marron, Andrew B. Nobel, Elaine R. Mardis, Torsten O. Nielsen, Matthew J. Ellis, Charles M. Perou, Philip S. Bernard
I whakaputaina 2023Artigo -
9
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression mā Maggie C.U. Cheang, Miguel Martín, Torsten O. Nielsen, Aleix Prat, David Voduc, Álvaro Rodríguez-Lescure, Amparo Ruı́z, Stephen Chia, Lois E. Shepherd, Manuel Ruíz‐Borrego, Lourdes Calvo, Emilio Alba, Eva Carrasco, Rosalía Caballero, Dongsheng Tu, Kathleen I. Pritchard, Mark N. Levine, Vivien Bramwell, Joel S. Parker, Philip S. Bernard, Matthew J. Ellis, Charles M. Perou, Angelo Di Leo, Lisa A. Carey
I whakaputaina 2015Artigo -
10
The prognostic effects of somatic mutations in ER-positive breast cancer mā Obi L. Griffith, Nicholas C. Spies, Meenakshi Anurag, Malachi Griffith, Jingqin Luo, Dongsheng Tu, Belinda Yeo, Jason Kunisaki, Christopher A. Miller, Kilannin Krysiak, Jasreet Hundal, Benjamin J. Ainscough, Zachary L. Skidmore, Katie M. Campbell, Runjun D. Kumar, Catrina C. Fronick, Lisa Cook, Jacqueline Snider, Sherri R. Davies, Shyam M. Kavuri, Eric C. Chang, Vincent Magrini, David E. Larson, Robert S. Fulton, Shuzhen Liu, Samuel Leung, David Voduc, Ron Bose, Mitch Dowsett, Richard K. Wilson, Torsten O. Nielsen, Elaine R. Mardis, Matthew J. Ellis
I whakaputaina 2018Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Medicine
Oncology
Breast cancer
Internal medicine
Biology
Pathology
Tissue microarray
Estrogen receptor
Immunohistochemistry
Anthracycline
Cancer research
Basal (medicine)
Biochemistry
Bioinformatics
Biomarker
Chemotherapy
Computational biology
Confidence interval
Gene
Genetics
Insulin
Lymph node
Progesterone receptor
Proportional hazards model
Biomarker discovery
Clinical Oncology
Computer science
Cyclophosphamide
Cytokeratin